Anthropometric and glucometabolic changes in an aged mouse model of lipocalin-2 overexpression
暂无分享,去创建一个
P. Castagnola | G. Sambuceti | F. Strollo | Roberta Pece | A. Buschiazzo | C. Marini | S. Tavella | D. Costa | E. Principi | I. Marić | Mara Scussolini | Andrea Papait | Delfina Costa | Andrea Papait
[1] R. Cancedda,et al. LCN2 overexpression in bone enhances the hematopoietic compartment via modulation of the bone marrow microenvironment , 2017, Journal of cellular physiology.
[2] M. Rubin,et al. MC4R-dependent suppression of appetite by bone-derived lipocalin 2 , 2017, Nature.
[3] Paul E Kinahan,et al. Brown Adipose Reporting Criteria in Imaging STudies (BARCIST 1.0): Recommendations for Standardized FDG-PET/CT Experiments in Humans. , 2016, Cell metabolism.
[4] F. Nevens,et al. Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis. , 2016, Journal of hepatology.
[5] P. Bruzzi,et al. Divergent targets of glycolysis and oxidative phosphorylation result in additive effects of metformin and starvation in colon and breast cancer , 2016, Scientific Reports.
[6] Sara Garbarino,et al. A new compartmental method for the analysis of liver FDG kinetics in small animal models , 2015, EJNMMI Research.
[7] S. Ravera,et al. Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models , 2015, Oncotarget.
[8] R. Cancedda,et al. Altered bone development and turnover in transgenic mice over‐expressing Lipocalin‐2 in bone , 2013, Journal of cellular physiology.
[9] C. Campi,et al. Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer , 2013, Cell cycle.
[10] Sushovan Guha,et al. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. , 2012, Biochimica et biophysica acta.
[11] J. H. Lee,et al. Emerging clinical and experimental evidence for the role of lipocalin‐2 in metabolic syndrome , 2012, Clinical and experimental pharmacology & physiology.
[12] C. Richart,et al. Upregulation of Lipocalin 2 in Adipose Tissues of Severely Obese Women: Positive Relationship With Proinflammatory Cytokines , 2011, Obesity.
[13] E. Rosen,et al. A minor role for lipocalin 2 in high-fat diet-induced glucose intolerance. , 2011, American journal of physiology. Endocrinology and metabolism.
[14] T. Clemens,et al. The osteoblast: An insulin target cell controlling glucose homeostasis , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[15] T. Mak,et al. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. , 2010, The Journal of clinical investigation.
[16] G. Shulman,et al. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice , 2010, Disease Models & Mechanisms.
[17] R. Cancedda,et al. Lipocalin-2 controls the expression of SDF-1 and the number of responsive cells in bone. , 2010, Cytokine.
[18] J. Kehrer. Lipocalin-2: pro- or anti-apoptotic? , 2010, Cell Biology and Toxicology.
[19] Wendy S. Wright,et al. Lipocalin-2 Deficiency Impairs Thermogenesis and Potentiates Diet-Induced Insulin Resistance in Mice , 2010, Diabetes.
[20] G Nolfe,et al. Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance , 2010, International Journal of Obesity.
[21] H. Randeva,et al. Ex Vivo and In Vivo Regulation of Lipocalin-2, a Novel Adipokine, by Insulin , 2009, Diabetes Care.
[22] Alan Aderem,et al. Lipocalin 2 is required for BCR-ABL-induced tumorigenesis , 2008, Oncogene.
[23] A. Xu,et al. Adipose tissue and the metabolic syndrome: focusing on adiponectin and several novel adipokines. , 2008, Biomarkers in medicine.
[24] Heike Münzberg,et al. Mechanisms of leptin action and leptin resistance. , 2008, Annual review of physiology.
[25] N. Houstis,et al. The Adipokine Lipocalin 2 Is Regulated by Obesity and Promotes Insulin Resistance , 2007, Diabetes.
[26] Laura Herrero,et al. Obesity, inflammation, and insulin resistance. , 2007, Gastroenterology.
[27] G. Hotamisligil,et al. Inflammation and metabolic disorders , 2006, Nature.
[28] A. Goldfine,et al. Inflammation and insulin resistance. , 2006, The Journal of clinical investigation.
[29] C. Mantzoros,et al. Drug Insight: the role of leptin in human physiology and pathophysiology—emerging clinical applications , 2006, Nature Clinical Practice Endocrinology &Metabolism.
[30] Shizuo Akira,et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron , 2004, Nature.
[31] I. S. Wood,et al. Adipokines: inflammation and the pleiotropic role of white adipose tissue , 2004, British Journal of Nutrition.
[32] M. Desai,et al. Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.
[33] R. Cancedda,et al. Extracellular fatty acid binding protein (Ex-FABP) modulation by inflammatory agents: "physiological" acute phase response in endochondral bone formation. , 2000, European journal of cell biology.
[34] M. Lindstrom,et al. Heterogeneous expression of the lipocalin NGAL in primary breast cancers , 1998, International journal of cancer.
[35] M. Mizumoto,et al. Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method. , 1998, Cancer letters.
[36] Quansheng Liu,et al. Uterocalin: A mouse acute phase protein expressed in the uterus around birth , 1997, Molecular reproduction and development.
[37] D R Flower,et al. The lipocalin protein family: structure and function. , 1996, The Biochemical journal.
[38] Quansheng Liu,et al. Identification of a New Acute Phase Protein (*) , 1995, The Journal of Biological Chemistry.
[39] R. Devos,et al. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. , 1995, Science.
[40] H. Tschesche,et al. Cloning and expression of human neutrophil lipocalin cDNA derived from bone marrow and ovarian cancer cells , 1995, FEBS letters.
[41] A. Van de Voorde,et al. Identification by microsequencing of lipopolysaccharide-induced proteins secreted by mouse macrophages. , 1993, Journal of immunology.
[42] G. Ailhaud,et al. Regulation of adipose cell differentiation. I. Fatty acids are inducers of the aP2 gene expression. , 1991, Journal of lipid research.
[43] C. Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[44] A. Harden. Obituary Notice: Adrian John Brown. , 1920, The Biochemical journal.
[45] E. Kraegen,et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. , 2007, Clinical chemistry.
[46] G. Steinberg,et al. Endurance training partially reverses dietary-induced leptin resistance in rodent skeletal muscle. , 2004, American journal of physiology. Endocrinology and metabolism.